Treatment of melanoma brain metastases
Explore this paper's citation graph
Summary
Advances in the treatment of melanoma are providing significant palliative benefit for patients with brain metastases and how these are integrated with local treatments to enable optimal palliation is discussed.
- Type
- article
- Published
- 2016-03-01
- Cited by
- 25
- References
- 71
- OpenAlex
- https://openalex.org/W26809015
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:23828416
Keywords
Legislation, Reservation, Event (particle physics), Business, Political science
References
- Complete loss of PTEN protein expression correlates with shorter time to brain metastasis and survival in stage IIIB/C melanoma patients with BRAFV600 mutations
- Severe radiotherapy-induced extracutaneous toxicity under vemurafenib.
- Potential role for LINAC-based stereotactic radiosurgery for the treatment of 5 or more radioresistant melanoma brain metastases.
- The melanoma-specific graded prognostic assessment does not adequately discriminate prognosis in a modern population with brain metastases from malignant melanoma
- Pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory melanoma (KEYNOTE-002): a randomised, controlled, phase 2 trial
- Genomic Classification of Cutaneous Melanoma
- Radiosurgery for melanoma brain metastases in the ipilimumab era and the possibility of longer survival
- Prognostic factors for survival in melanoma patients with brain metastases
- Targeting hyperactivation of the AKT survival pathway to overcome therapy resistance of melanoma brain metastases
- Ipilimumab and radiation therapy for melanoma brain metastases
- Stereotactic radiosurgery alone for brain metastases.
- Vemurafenib in patients with BRAF(V600) mutation-positive melanoma with symptomatic brain metastases: final results of an open-label pilot study.
- Ipilimumab in melanoma with limited brain metastases treated with stereotactic radiosurgery
- Stereotactic radiosurgery for the treatment of brain metastases.
- Radiation and Dual Checkpoint Blockade Activates Non-Redundant Immune Mechanisms in Cancer
- Local control after stereotactic radiosurgery for brain metastases in patients with melanoma with and without BRAF mutation and treatment.
- The treatment of melanoma brain metastases before the advent of targeted therapies: associations between therapeutic choice, clinical symptoms and outcome with survival
- Vemurafenib-Induced Radiation Recall Dermatitis: Case Report and Review of the Literature
- Survival of melanoma patients with brain metastases treated with ipilimumab and stereotactic radiosurgery
- Temozolomide, thalidomide, and whole brain radiation therapy for patients with brain metastasis from metastatic melanoma
Cited by
- Dabrafenib for the treatment of melanoma
- Management of Brain Metastases in Patients With Melanoma.
- Melanoma Brain Metastasis: Mechanisms, Models, and Medicine
- A Case of Vanishing Brain Metastasis in a Melanoma Patient on Nivolumab.
- Entscheidungsfindung für die klinische Praxis: Aktuelle Konzepte und Behandlungsalgorithmen mit Immun-Checkpoint-Inhibitoren beim Melanom
- Long term survival after brain metastases from malignant melanoma
- Clinical aspects of molecular profiles in metastatic malignant melanoma
- Molecular insights into melanoma brain metastases
- Immuno-radiotherapy for brain metastases
- Rapid exacerbation of malignant melanoma during short‐term discontinuation of vemurafenib
- Targeted Therapy and Immunotherapy Response Assessment with F-18 Fluorothymidine Positron-Emission Tomography/Magnetic Resonance Imaging in Melanoma Brain Metastasis: A Pilot Study
- Improved Risk-Adjusted Survival for Melanoma Brain Metastases in the Era of Checkpoint Blockade Immunotherapies: Results from a National Cohort
- Clinical experience with combination BRAF/MEK inhibitors for melanoma with brain metastases: a real-life multicenter study
- [Mucosal melanoma primary and metastatic cases with urogenital localization in our department].
- Outcomes of Treatment for Melanoma Brain Metastases
- Real-life data for first-line combination immune-checkpoint inhibition and targeted therapy in patients with melanoma brain metastases.
- Practical Manual for Dermatologic and Surgical Melanoma Management
- Metastatic Malignant Melanoma of Brain: A Rare Case Report
- Survival benefits and toxicity effects of radiotherapy and immunotherapy treatments in melanoma patients with brain metastases: A meta-analysis study
- Brain MRI and regional vulnerabilities to radiation necrosis: investigating the impact of stereotactic radiotherapy in brain metastases treatment
Related papers
No related papers recorded.